Pennings, Elise R. A.
Spanjaart, Anne M.
Schaaphok, Anne Ruth
van Maanen, Marjolein A.
Tonino, Sanne H.
Kuipers, Maria T.
Kersten, Marie José
Metselaar, Suzanne https://orcid.org/0000-0001-9214-6477
Article History
Received: 3 February 2025
Accepted: 1 January 2026
First Online: 12 February 2026
Declarations
:
: SHT received honoraria from and has a consulting/advisory role for Takeda, Roche, and BMS (all paid to the institution). MTK has a consulting/advisory role for CellPoint. MJK received honoraria from and has a consulting/advisory role for BMS/Celgene, Kite, a Gilead Company, Miltenyi Biotec, Galapagos, Novartis, Adicet Bio, Mustang Bio, Janssen, AbbVie and Roche, research funding from Kite, a Gilead Company, and travel support from AbbVie and Janssen (all to institution). ERAP, AMS, ARS, MAvM and SM declare no conflict of interest.
: The study was conducted in accordance with the Declaration of Helsinki and approved by the Medical Ethics Review Committee of the Academic Medical Center.
: Informed consent was obtained to participate in the study, audio record the session and for publication of the case example.